Welcome to the Empowered Patient Podcast with Karen Jagoda. This show is a window into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the changing dynamics in the medical and healthcare environment. One focus is on how providers, pharmaceutical companies, and payers are empowering patients. In addition, conversations are often about how providers, care facilities, pharmaceutical companies, and payers are being empowered by technology to improve patient outcomes and reduce friction across the healthcare landscape.
Popular Topics
- Virtual and digital health
- Use of AI, ML, and LLM in healthcare and drug discovery, development, trials
- Value-based healthcare
- Precision and stratified medicine
- Integration of digital technology into existing workflow and procedures
- Next-generation immuno, cell, and gene therapies
- Vaccines
- Biomarkers, sequencing, and imaging
- Rare diseases
- MedTech and medical devices
- Clinical trials
- Addressing Social Determinants of Health
- Treating chronic conditions like obesity and pain
- Clinician and staff burnout
The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.
Check out our new EmpoweredPatient.Solutions site where you can quickly search all of the Empowered Patient Podcast interviews by any word or phrase to identify useful resources, potential partners, and insights about the life sciences landscape.
Intratumoral Therapy the Abscopal Effect and Harnessing Cytokine IL-12 in the Treatment Melanoma with Daniel O’Connor OncoSec Immunotherapies TRANSCRIPT
Download PDFNov 30, 2020
Daniel O'Connor, CEO, OncoSec Immunotherapies describes their intratumoral therapy where the drug is injected directly into tumors instead of a systemic treatment thereby avoiding toxicities while also seeing tumors shrink that are not being directly treated, the abscopal effect. OncoSec is using electroporation to deliver interleukin-12 into cells. IL-12 is considered to be one of the most potent cytokines to fight cancer and their drug TAVO is being tested in conjunction with KEYTRUDA to help patients with melanoma not responding to current treatments.
@oncosec #oncology #cancer #interleukin-12 #IL-12 #melanoma #breastcancer #TAVO #immunotherapy $ONCS
